Search Results
Results found for "Dr. Simone Promel"
- Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors
Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Thank you to all participants in Dr. Terry Kenakin's educational initiative this fall!
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
Chris Cargill appointed as President and Chief Executive Officer • Dr.
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE
- Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...
Ginsenoside Rg1, Polygalaxanthone III and Pachymic acid, could interact with multiple targets (5-HTR, DR
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
experience, you MUST get our Premium Membership and begin taking advantage of our exceptional features: Dr Direct line to the Dr. GPCR community members Join the GPCR fan club and geek out with fellows!
- Target Residence Time: The Hidden Driver of In Vivo Efficacy
Here’s what members get: Weekly deep dives from Dr.
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- 📰 GPCR Weekly News, January 30 to February 5, 2023
For Dr. GPCR News, please subscribe to your monthly newsletter. Research Fellow - School of Physics and Astronomy Postdoctoral Research Associate (Fixed Term) Explore Dr
- Why “Displacement” Misleads You: Allosteric Binding Demystified
As a member, you’ll get: Weekly expert-led lectures from Dr.
- 📢 GPCR Update: August 19-25, 2024 | Thrilling Announcement: New Pharmacology Course Dates & Exclusive Discounts Inside!
premium member , you can access over 500 minutes of exclusive, expert-led content from esteemed leaders, Drs
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
Subscribers gain access to: Weekly lessons by Dr.
- Why Intracellular Drugs May Hold the Key to GPCR Therapeutics
Here ’s what members get: Weekly deep dives from Dr.
- Embark on a GPCR Adventure: Your Weekly Research Expedition! | Oct 21-27, 2024
Thank you to all participants in Dr. Terry Kenakin's educational initiative this fall!
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
At Dr. GPCR, we recognized this core problem.
- 📰 GPCR Weekly News - January 2 to 8, 2023
Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
postdoctoral training at Boston Children’s Hospital and Harvard Medical School, he joined the lab of Dr
- 📰 GPCR Weekly News, January 23 to 29, 2023
of Staff Postdoctoral Fellow, Biochemical And Cellular Pharmacology Project Leader, Biology Explore Dr
- 📰 GPCR Weekly News - January 9 to 15, 2023
Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel P2y Receptor Ligands For Drug Discovery Explore Dr
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
, you’re also unlocking over 500 minutes of exclusive, expert-led content from thought leaders like Drs
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
It's starting to look a lot like Christmas at Dr. GPCR!
- Discover the Hottest GPCR News of the Week: Oct 7-13, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- GPCR Buzz of the Week | Sep 23 - 29, 2024
live and work in a developing country, please complete this form to enjoy complimentary access to Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- GPCR Weekly Whirlwind: Top Receptor Highlights from Sep 30 - Oct 6, 2024!
Developing Nations If you reside and work in a developing country, complete this form for free access to Dr
- 📰 GPCR Weekly News
Explore Dr. GPCR Ecosystem
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
IGF1, in turn, stimulated GASP1 expression by activating the PI3K/AKT pathway, forming a vicious cycle propelling
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
As technology continues to advance, leveraging RET-based sensors will undoubtedly continue to propel
